BMO Capital Maintains Outperform on Morphic Holding, Lowers Price Target to $30

BMO Capital maintains Morphic Holding (NASDAQ:MORF) with a Outperform and lowers the price target from $32 to $30.

Benzinga · 11/13/2019 14:13

BMO Capital maintains Morphic Holding (NASDAQ:MORF) with a Outperform and lowers the price target from $32 to $30.